Therapeutic uses of Dunaliella powder
US7264813B2 · kind B2 · utility
3Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 24, 2003 |
| Grant date | Sep 4, 2007 |
| Priority date | — |
| Expiry date | Sep 24, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.